<?xml version="1.0" encoding="UTF-8"?>
<fig fig-type="Figure" xml:lang="en" id="advs2293-fig-0004" orientation="portrait" position="float">
 <label>Figure 4</label>
 <caption>
  <p>Presence of low‐level serum inflammation and antigluten immunity at baseline in "responder" patients. A) Comparison of clinical biochemistry and cytokines measured at baseline before challenge for “responders” and “non‐responders” (Mann‐Whitney U test). B) Frequency of gluten specific CD4+ T‐cells per million CD4+ T‐cells from gut biopsies collected at baseline (left, P2, P5, P7, P11, P12, P13, and P14)
   <sup>[</sup>
   <xref rid="advs2293-bib-0003" ref-type="ref">
    <sup>3</sup>
   </xref>
   <sup>]</sup> and gluten‐specific gut homing effector memory T‐cells per million CD4+ T‐cells in blood at baseline.
   <sup>[</sup>
   <xref rid="advs2293-bib-0006" ref-type="ref">
    <sup>6</sup>
   </xref>
   <sup>]</sup> (Mann‐Whitney U test). C) Duration of gluten‐free diet before gluten challenge. D) Correlation between mature enterocyte protein expression (from total tissue data) (top row) or Vh:Cd ratio (bottom row) with gluten‐specific CD4+ T‐cell frequencies at baseline in gut (left) and blood (middle) for patients P2, P5, P7, P11, P12, P13, and P14, and blood (right) for all patients (Pearson correlation).
  </p>
 </caption>
 <graphic id="nlm-graphic-9" xlink:href="ADVS-8-2003526-g004" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
